Loading...
Market
What will Rapport Therapeutics' stock price be by December 31, 2024?
5
Resolution / Starting Odds
Below $10 • 33%
$10 to $20 • 34%
Above $20 • 33%
NASDAQ or other stock market data providers
Story
Rapport Therapeutics Prices IPO at $17 Per Share for 8 Million Shares, Raises $136 Million
Jun 7, 2024, 12:25 AM
Rapport Therapeutics Inc. (RAPP) has successfully priced its initial public offering (IPO), setting the stage for its debut on Friday. The company priced a full size deal of 8 million shares at $17 each, which is the midpoint of the expected range. The IPO has raised $136 million, and the offering is backed by prominent investors including Johnson & Johnson (JNJ). The pricing of the IPO marks a significant milestone for Rapport Therapeutics as it prepares to enter the public market.
View original story
Similar markets
Below $100M • 33%
$100M-$200M • 33%
Above $200M • 33%
Below $50 • 33%
Between $50 and $100 • 33%
Above $100 • 33%
Increase by more than 20% • 33%
Increase by 0-20% • 33%
Decrease • 33%
Less than $50 • 25%
$50 to $75 • 25%
$75 to $100 • 25%
More than $100 • 25%
